Receive The Newest Study Notifications

-- Trial is to Assess Pharmacokinetics, Pharmacodynamics and Safety of the Oral Administration of MNK-6106 in Patients with HE -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today confirmed enrollment of the first patient in the company's Phase...

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today announced that the Company has...

CStone Pharmaceuticals ("CStone", HKEX: 2616) today announces the dosing of the first patient in China for the Phase I registrational study of BLU-667, which was discovered by the company's partner Blueprint Medicines. This clinical trial is a part of the ongoing,...

A preclinical trial of a tenofovir disoproxil fumarate (TDF) intravaginal ring for HIV pre-exposure prophylaxis ended early after 8 of 12 women unexpectedly developed vaginal ulcers. The National Institutes of Health-funded study, published in The Lancet, included 17...

 I Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing potentially best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced enrollment of the first patient in an...

 Saul Priceman, Ph.D., City of Hope assistant professor in the Department of Hematology & Hematopoietic Cell Transplantation, and his research team have received a $9.28 million award from the California Institute for Regenerative Medicine (CIRM) to support a...

  TEL AVIV, Israel, Aug. 12, 2019 /PRNewswire/ -- Following the one month data of the 9th patient, the Data and Safety Monitoring Board (DSMB) reviewed the safety data from Cellect Biotechnology Ltd.'s (Nasdaq: APOP)  ongoing Phase 1/2 clinical study of...

Mark Terry for Biospace writes: Last week was a particularly busy week for biopharma companies to release information about ongoing clinical trials. Here’s a look. Pfizer announced that its Phase III RESET clinical trial evaluating rivipansel in sickle cell disease...

A Stamford clinical trial center is seeking participants in a new study that targets Alzheimer’s disease, a progressive, degenerative neurologic disease which currently affects 5.7 million Americans. New England Institute for Clinical Research is one of 40 medical and...

Oncologie, Inc. Announces Clinical Trial Collaboration With Merck to Evaluate Bavituximab in Combination With KEYTRUDA® (Pembrolizumab) in Advanced Gastric or Gastroesophageal Cancer Oncologie, Inc., a clinical-stage biopharmaceutical company developing innovative...

Results from single-ascending dose cohorts demonstrate that TERN-201 is generally safe and well tolerated and results in sustained inhibition of plasma SSAO activity The trial has now progressed to the multiple-ascending dose phase Terns Pharmaceuticals, Inc., a...

Company Expects to Report Top-Line Results from the Study by the end of October 2019 PolyPid Ltd., a clinical-stage biopharmaceutical company focused on developing and commercializing novel, locally administered therapies, announced today that it has completed patient...

- Study Being Conducted in Collaboration with Investigators at Arizona State University and the Mayo Clinic - Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing potentially best-in-class, oral therapies for the treatment of...

Biohit Oyj Stock Exchange Release August 9th 2019 at 15.30 pm local time (EET) In 2014, Biohit Oyj initiated two clinical trials for prevention of migraine-type headache attacks, testing the efficacy of Acetium® capsule. Because of a slow patient enrollment, the trial...

The main purpose of a study pipeline is to illustrate the progress of a clinical study, from beginning to end. From the discovering of potential treatments to the application of said treatments, all the way to the filing process, there is ample information that must...

Elysium Health, Inc.,™ a life sciences company developing clinically validated health products based on aging research, today announced the initiation of a clinical trial at University of Exeter, UK to explore the effects of Basis™ and high-intensity interval training...

89Bio Ltd. (89bio), a clinical-stage biopharmaceutical company, today announced that the first patients have been screened in its proof of concept Phase 1b/2a clinical trial evaluating its investigational product candidate, BIO89-100, a glycoPEGylated analog of...

Geron Corporation (Nasdaq: GERN) today announced the opening of patient screening and enrollment for the Phase 3 portion of IMerge to evaluate imetelstat, a first-in-class telomerase inhibitor, in lower risk myelodysplastic syndromes (MDS). “The start of the Phase 3...

Pharmaceutical companies could reduce the cost of drug development thanks to a new partnership that aims to scale the next generation of digital clinical trials. Expand Global technology company HCL Technologies (HCL) has teamed up with Oracle Health Sciences to help...

  -Bispecific Diabody Designed to Intercept B-Cell Mediated Autoimmune Diseases- Provention Bio, Inc. (Nasdaq: PRVB), a clinical stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that it has dosed...